Bordeaux, Boston, April 21st, 2020 – 5:45pm CEST: IMPLANET (Euronext Growth: ALIMP, FR0013470168, eligible for PEA-PME equity savings plans), a medical technology company specializing in vertebral and knee-surgery implants, today announced its revenue for the first quarter of 2020.Before the impact of Covid-19, Implanet had a brisk start to the year and posted revenue of …